Bewtra, Meenakshi; Schreiber, Stefan; Buisson, Anthony; Hur, Peter; Panattoni, Laura; Hauber, Brett; Gahlon, Grace; Coulter, Josh; Smith, Christina; Guo, Xiang; Land, Natalie; Wosik, Karolina; Cappelleri, Joseph; Maravic, Melissa Culhane; Walsh, Alissa Comparing the benefit-risk tradeoffs advanced therapy naïve vs experienced patients are willing to accept when selecting advanced therapy for moderate-to-severe ulcerative colitis: A discrete choice experiment in the United States and Europe , Digestive Disease Week, San Diego CA: 2025
Regueiro MD, Bewtra M, Dubinsky MC, Branquinho D, Feng C, McDonnell A, Gianfrancesco MA. Safety Outcomes in Patients With Ulcerative Colitis Using a Healthcare Administrative Database in the United States , Inflamm Bowel Dis: 2025
Kruger AJ, Dormont F, Capit N, Schilsky S, Roberts A, Lin Y, Badalamenti S, Wiekowski M, Bewtra M, Colombel JF. Biologic Switch Timing and Risk of Infection in Patients With Ulcerative Colitis/Crohn's Disease: A Retrospective Study , Clin Gastroenterol Hepatol: 2025
Yang JC, Janssen EM, Wallace MJ, Sheahan A, Lynch J, Bewtra M, Marko M, Johnson FR, Bozzi LM. Quantifying Patient Preferences for Risk Tolerance With Novel Dual Biologic Therapies for Inflammatory Bowel Disease , Am J Gastroenterol: 2025
Schreiber, Stefan; Buisson, Anthony; Bewtra, Meenakshi; Hur, Peter; Panattoni, Laura; Hauber, Brett; Land, Natalie; Coulter, Josh; Gahlon, Grace; Guo, Xiang; Smith, Christina C.; Cappelleri, Joseph C.; Wosik, Karolina; Maravic, Melissa Culhane; Walsh, Alissa Quantifying the benefit-risk trade-offs adult patients and providers
are willing to make when considering advanced therapies for
moderate to severe Ulcerative Colitis: A discrete choice experiment , European Crohn’s and Colitis Organisation 2025; Berlin Germany: 2025
Sehgal P, Lewis JD, Pickett-Blakely O, Nandi N, Bewtra M, Lichtenstein GR. Safety and Clinical Effectiveness of GLP1 Receptor Agonists in Inflammatory Bowel Disease Patients , Clin Gastroenterol Hepatol: 2025
Kastl AJ, Brenner EJ, Weaver KN, Zhang X, Strople JA, Adler J, Dubinsky MC, Bousvaros A, Watkins R, Dai X, Chen W, Cross RK, Higgins PDR, Ungaro RC, Bewtra M, Bellaguarda EA, Farraye FA, Chun KY, Zikry M, Bastidas M, Firestine AM, Craig RG, Boccieri ME, Long MD, Kappelman MD. Durable Immune Response and Long-term Efficacy of COVID-19 Vaccination in Children With Inflammatory Bowel Disease , Inflamm Bowel Dis: 2024
Motwani KK, Alizadeh M, Abutaleb A, Grossman J, Wellington J, Cross RK; SPARC-IBD investigators. Correlation Between Serum and Fecal Biomarkers and Patient-Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis , Dig Dis Sci: 2024
Motwani KK, Alizadeh M, Abutaleb A, Grossman J, Wellington J, Cross RK; SPARC-IBD investigators. Correction to: Correlation Between Plasma and Fecal Biomarkers and Patient‑Reported Outcomes in Patients with Crohn's Disease and Ulcerative Colitis , Dig Dis Sci: 2024
Karakasheva TA; Martinez CM; Zhou Y; Rhoades JH; Soto GE; Hix OT; Nettleford SK; Roach DM; Laguerta AM; Thadi A; Aleynick D; Pickering OH; Borodyanskaya Y; Fulton M; Uzun Y; Li N; Bewtra M; Kelsen JR; Tan K; Minn AJ; Lengner CJ; Hamilton KE; Crohn's Disease Epithelial Cells Exhibit Sustained Inflammatory Progenitor Cell States
, Digestive Disease Week, Washington DC: 2024
